Filing Flows › Elanco Animal Health (ELAN) › R&D spending
Elanco Animal Health (ELAN) R&D spending by quarter
Elanco Animal Health's R&D spending was $99.0M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 7 quarters it ranged from $89.0M (Q3 2025) to $99.0M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $99.0M | +8% | +11% |
| Q2 2026 | $92.0M | -5% | 0% |
| Q1 2026 | $97.0M | +4% | +3% |
| Q4 2025 | $93.0M | +4% | — |
| Q3 2025 | $89.0M | -3% | — |
| Q2 2025 | $92.0M | -2% | — |
| Q1 2025 | $94.0M | — | — |
Q3 2026 at a glance
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elanco Animal Health's R&D spending?
Elanco Animal Health's R&D spending was $99.0M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Elanco Animal Health's R&D spending changed?
Over the last 7 quarters it ranged from $89.0M (Q3 2025) to $99.0M (Q3 2026).